prognostic biomarkers of immunotherapy efficacy in breast cancer
Published 1 year ago • 123 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
1:55
predictive biomarkers in breast cancer
-
3:39
foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
-
6:08
prognostic biomarkers in breast cancer – the latest developments
-
1:03
elucidating immunotherapy biomarkers for breast cancer
-
6:45
innovative biomarker approaches in breast cancer therapy
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
2:05
immunotherapy in breast cancer
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
2:15
i-spy2.2: emerging biomarkers in breast cancer
-
5:16
predictive biomarkers for immunotherapy in upper gi cancers
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
3:17
multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer
-
1:45
identifying novel predictive biomarkers in breast cancer
-
1:29
the challenges of using biomarkers for immunotherapy
-
1:08
the role of immunotherapy in endocrine-refractory luminal breast cancer
-
2:38
assessing the role of parp inhibitors and immunotherapy in ovarian cancer
-
7:09
personalizing immunotherapy beyond pdl1 expression